The arrival of off-brand imatinib represents a significant possibility for patients battling chronic myeloid leukemia and other conditions. Original brand-name imatinib, commonly known as Gleevec, carries a https://imatinib-400-mg559157.blogdeazar.com/543686/common-gleevec-a-cost-effective-alternative